GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Deferred Tax

Reunion Neuroscience (TSX:REUN) Deferred Tax : C$0.00 Mil (TTM As of Mar. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Reunion Neuroscience's change in deferred tax for the three months ended in Mar. 2023 was C$0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2023 was C$0.00 Mil.

Reunion Neuroscience Deferred Tax Historical Data

The historical data trend for Reunion Neuroscience's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reunion Neuroscience Deferred Tax Chart

Reunion Neuroscience Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Deferred Tax
- - - -

Reunion Neuroscience Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Reunion Neuroscience Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reunion Neuroscience Deferred Tax Related Terms

Thank you for viewing the detailed overview of Reunion Neuroscience's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Reunion Neuroscience (TSX:REUN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Deferred Tax
Comparable Companies
TSX:GTMS TSX:NUMI TSXV:SLHG XCNQ:CBDT TSXV:NLH TSXV:PHA TSX:DRDR TSXV:NPTH TSXV:KDA XCNQ:NM HCA SZSE:300015 XTER:FRE SAU:4013 HKSE:06618 XTER:FME BSP:RDOR3 XKLS:5225 ASX:RHC BKK:BDMS
Traded in Other Exchanges
N/A
Address
30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3
Website
https://www.reunionneuro.com
Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.